Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

CLOV

Clover Health Investments, Corp. · Healthcare · Medical - Healthcare Plans

4.18 +1.1% mkt cap $2.16B quote delayed (FMP) · as of Aug 26 16:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
8Tracked holders
+1Δ holders
20.89MShares held
$58.90MReported value
+2New positions
−1Exits
Strongly Rising Conviction score 57/100 How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +14.3% · share flow +8.4% · net new positions +12.5%formula
Broad accumulation — rising shares across more holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 85 +6 128.61M $672.46M +12 −6
Q1 2026 82 +5 113.55M $200.08M +10 −5
Q4 2025 76 -1 119.92M $281.85M −1
Q3 2025 14 -2 85.90M $262.85M −2
Q2 2025 13 +1 91.13M $254.25M +1
Q1 2025 9 0 31.30M $112.39M +2 −2
Q4 2024 9 0 25.46M $80.20M
Q3 2024 8 +1 20.89M $58.90M +2 −1
Q2 2024 7 19.27M $23.70M
Holder count
Who holds it · Q3 2024
#ManagerSharesΔ sharesValueTheir weightHeld
1 Renaissance Technologies 12.48M +10.7% $35.19M 0.1% ▲ Add 2 SEC ↗
2 Geode Capital Management (passive) 4.83M +21.9% $13.62M 0.0% ▲ Add 2 SEC ↗
3 Geode Capital Management (passive) 4.83M +21.9% $13.62M 0.0% ▲ Add 2 SEC ↗
4 Two Sigma Investments 1.64M +16.9% $4.62M 0.0% ▲ Add 2 SEC ↗
5 Marshall Wace 1.41M +3040.9% $3.97M 0.0% ▲ Add 2 SEC ↗
6 Marshall Wace 1.41M +3040.9% $3.97M 0.0% ▲ Add 2 SEC ↗
7 Point72 Asset Management 260.65K New $735,032 0.0% New 1 SEC ↗
8 Citadel Advisors 143.85K -91.3% $405,654 0.0% ▼ Trim 2 SEC ↗
9 Citadel Advisors 143.85K -91.3% $405,654 0.0% ▼ Trim 2 SEC ↗
10 Gotham Asset Management 101.42K New $286,002 0.0% New 1 SEC ↗
11 Millennium Management 24.09K -88.2% $67,931 0.0% ▼ Trim 2 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Point72 Asset Management $735,032 0.0%
Gotham Asset Management $286,002 0.0%

Exited

AQR Capital Management $897,538 was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 207 holders, 127.13M shares, $218.62M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Insider transactions

Open-market purchases (P)

No open-market insider purchases in our coverage window.

Open-market sales (S)

Aug 17 THORNTON JOSEPH CLAY

Officer · 17.77K sh · $78,032

Aug 10 Toy Andrew

Officer, Director · 87.80K sh · $408,261

Awards, exercises and tax withholding are never counted as buys or sales here. Methodology

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q3 2024 · Methodology · Get this via the API